19 Jul FibroBiologics
Hamid Khoja, Ph.D., Chief Scientific Officer
Oct. 10 | 10:45am | Rentschler ATMP Ballroom
FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments for chronic diseases using fibroblast cells. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.